Agreement - February 18, 2015
Astra to Pay $7.9M U.S. Fine
AstraZeneca has agreed to pay American authorities $7.9 million to settle allegations the company engaged in a kickback scheme with Medco Health Solutions, a pharmacy benefit managers, to boost sales of its heartburn medication Nexium, according to a BioSpace article. “AstraZeneca embarked on this course of unlawful conduct knowing it would lead to the submission […]
Drug Development Pharma - January 28, 2015
FDA Approves Generic Nexium
AstraZeneca’s extended protection period for the $3 billion-selling heartburn drug Nexium has come to an end, now that the U.S. Food and Drug Administration (FDA) has approved the first generic version of Nexium. Ivax Pharmaceuticals, Inc., a subsidiary of Teva Pharmaceuticals USA, has won approval to market the medication in 20 and 40 milligram capsules. […]
